Worth the Weight? The Challenges of Administering the Glucagon-Like Peptide 1 Receptor Agonist Semaglutide With Long-Term Olanzapine Use in a Patient With Schizophrenia

Kantrowitz, J. T., Ricciardi, F. L., Melnitsky, J. L., Peleg, S. B., & Govil, P. (2025). Worth the Weight? The Challenges of Administering the Glucagon-Like Peptide 1 Receptor Agonist Semaglutide With Long-Term Olanzapine Use in a Patient With Schizophrenia. The Journal of Clinical Psychiatry, 86(3). https://doi.org/10.4088/jcp.25cr15857

Authors:

Francesca L Ricciardi

Jayda L Melnitsky

Shannon B Peleg

Preetika Govil

Joshua T Kantrowitz

Affiliated Authors:

Joshua T Kantrowitz

Columbia Affiliation: